|
1
|
Chaudhari VA, Khobragade K, Bhandare M and
Shrikhande SV: Management of fibrolamellar hepatocellular
carcinoma. Chin Clin Oncol. 7:512018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thompson AI, Conroy KP and Henderson NC:
Hepatic stellate cells: Central modulators of hepatic
carcinogenesis. BMC Gastroenterol. 15:632015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petruzziello A: Epidemiology of hepatitis
B virus (HBV) and hepatitis C virus (HCV) related hepatocellular
carcinoma. Open Virol J. 12:26–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang X and Liu W: Long noncoding RNA
highly upregulated in liver cancer activates p53-p21 pathway and
promotes nasopharyngeal carcinoma cell growth. DNA Cell Biol.
36:596–602. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liao K, Qian Z, Zhang S, Chen B, Li Z,
Huang R, Cheng L, Wang T, Yang R, Lan J, et al: The LGMN pseudogene
promotes tumor progression by acting as a miR-495-3p sponge in
glioblastoma. Cancer Lett. 490:111–123. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
García-Venzor A, Mandujano-Tinoco EA,
Ruiz-Silvestre A, Sánchez JM, Lizarraga F, Zampedri C,
Melendez-Zajgla J and Maldonado V: lncMat2B regulated by severe
hypoxia induces cisplatin resistance by increasing DNA damage
repair and tumor-initiating population in breast cancer cells.
Carcinogenesis. 41:1485–1497. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Huang W, Yuan Y, Li J, Wu J, Yu
J, He Y, Wei Z and Zhang C: Long non-coding RNA H19 promotes
colorectal cancer metastasis via binding to hnRNPA2B1. J Exp Clin
Cancer Res. 39:1412020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Das M, Renganathan A, Dighe SN, Bhaduri U,
Shettar A, Mukherjee G, Kondaiah P and Satyanarayana Rao MR:
DDX5/p68 associated lncRNA LOC284454 is differentially expressed in
human cancers and modulates gene expression. RNA Biol. 15:214–230.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan C, Wang J, Tang Y, Zhang S, Xiong F,
Guo C, Zhou Y, Li Z, Li X, Li Y, et al: Upregulation of long
non-coding RNA LOC284454 may serve as a new serum diagnostic
biomarker for head and neck cancers. BMC Cancer. 20:9172020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan C, Tang Y, Wang J, Wang Y, Xiong F,
Zhang S, Li X, Xiang B, Wu X, Guo C, et al: Long non-coding RNA
LOC284454 promotes migration and invasion of nasopharyngeal
carcinoma via modulating the Rho/Rac signaling pathway.
Carcinogenesis. 40:380–391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Creighton CJ, Gibbons DL and Kurie JM: The
role of epithelial-mesenchymal transition programming in invasion
and metastasis: A clinical perspective. Cancer Manag Res.
5:187–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han LL, Jia L, Wu F and Huang C: Sirtuin6
(SIRT6) promotes the EMT of hepatocellular carcinoma by stimulating
autophagic degradation of E-cadherin. Mol Cancer Res. 17:2267–2280.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou W, Gong L, Wu Q, Xing C, Wei B, Chen
T, Zhou Y, Yin S, Jiang B, Xie H, et al: PHF8 upregulation
contributes to autophagic degradation of E-cadherin,
epithelial-mesenchymal transition and metastasis in hepatocellular
carcinoma. J Exp Clin Cancer Res. 37:2152018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee CH, Yu JR, Granat J, Saldaña-Meyer R,
Andrade J, LeRoy G, Jin Y, Lund P, Stafford JM, Garcia BA, et al:
Automethylation of PRC2 promotes H3K27 methylation and is impaired
in H3K27M pediatric glioma. Genes Dev. 33:1428–1440. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding J, Li J, Wang H, Tian Y, Xie M, He X,
Ji H, Ma Z, Hui B, Wang K and Ji G: Long noncoding RNA CRNDE
promotes colorectal cancer cell proliferation via epigenetically
silencing DUSP5/CDKN1A expression. Cell Death Dis. 8:e29972017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lian Y, Yan C, Xu H, Yang J, Yu Y, Zhou J,
Shi Y, Ren J, Ji G and Wang K: A novel lncRNA, LINC00460, affects
cell proliferation and apoptosis by regulating KLF2 and CUL4A
expression in colorectal cancer. Mol Ther Nucleic Acids.
12:684–697. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kumar MB, Lu JJ, Loh KS, Chong LM, Soo R,
Goh BC, Tan KS and Shakespeare TP: Tailoring distant metastatic
imaging for patients with clinically localized undifferentiated
nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 58:688–693.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cantù G, Bimbi G, Miceli R, Mariani L,
Colombo S, Riccio S, Squadrelli M, Battisti A, Pompilio M and Rossi
M: Lymph node metastases in malignant tumors of the paranasal
sinuses: Prognostic value and treatment. Arch Otolaryngol Head Neck
Surg. 134:170–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Q, Wang WW, Xu TH and Xu ZF: Highly
expressed long non-coding RNA DUXAP10 promotes proliferation of
ovarian cancer. Eur Rev Med Pharmacol Sci. 22:314–321.
2018.PubMed/NCBI
|
|
23
|
Oka H, Shiozaki H, Kobayashi K, Inoue M,
Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S,
Takeichi M, et al: Expression of E-cadherin cell adhesion molecules
in human breast cancer tissues and its relationship to metastasis.
Cancer Res. 53:1696–1701. 1993.PubMed/NCBI
|
|
24
|
Schipper JH, Frixen UH, Behrens J, Unger
A, Jahnke K and Birchmeier W: E-cadherin expression in squamous
cell carcinomas of head and neck: Inverse correlation with tumor
dedifferentiation and lymph node metastasis. Cancer Res.
51:6328–6337. 1991.PubMed/NCBI
|
|
25
|
Li X, Zhang F, Ma J, Ruan X, Liu X, Zheng
J, Liu Y, Cao S, Shen S, Shao L, et al: NCBP3/SNHG6 inhibits GBX2
transcription in a histone modification manner to facilitate the
malignant biological behaviour of glioma cells. RNA Biol. 26:1–17.
2020. View Article : Google Scholar
|
|
26
|
Zhang F, Ruan X, Ma J, Liu X, Zheng J, Liu
Y, Liu L, Shen S, Shao L, Wang D, et al: DGCR8/ZFAT-AS1 promotes
CDX2 transcription in a PRC2 complex-dependent manner to facilitate
the malignant biological behavior of glioma cells. Mol Ther.
28:613–630. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Goodrich KJ, Conlon EG, Gao J,
Erbse AH, Manley JL and Cech TR: C9orf72 and triplet repeat
disorder RNAs: G-quadruplex formation, binding to PRC2 and
implications for disease mechanisms. RNA. 25:935–947. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He W, Yu Y, Huang W, Feng G and Li J: The
pseudogene DUXAP8 promotes colorectal cancer cell proliferation,
invasion, and migration by inducing epithelial-mesenchymal
transition through interacting with EZH2 and H3K27me3. Onco Targets
Ther. 13:11059–11070. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen WW, Qi JW, Hang Y, Wu JX, Zhou XX,
Chen JZ, Wang J and Wang HH: Simvastatin is beneficial to lung
cancer progression by inducing METTL3-induced m6A modification on
EZH2 mRNA. Eur Rev Med Pharmacol Sci. 24:4263–4270. 2020.PubMed/NCBI
|
|
30
|
Chen Y, Yang F, Fang E, Xiao W, Mei H, Li
H, Li D, Song H, Wang J, Hong M, et al: Circular RNA circAGO2
drives cancer progression through facilitating HuR-repressed
functions of AGO2-miRNA complexes. Cell Death Differ. 26:1346–1364.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gu X, Li H, Sha L and Zhao W: A prognostic
model composed of four long noncoding RNAs predicts the overall
survival of Asian patients with hepatocellular carcinoma. Cancer
Med. 9:5719–5730. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16:1362017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu J, Xu R, Mai SJ, Ma YS, Zhang MY, Cao
PS, Weng NQ, Wang RQ, Cao D, Wei W, et al: lncRNA CSMD1-1 promotes
the progression of Hepatocellular Carcinoma by activating MYC
signaling. Theranostics. 10:7527–7544. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Choi JM, Holehouse AS, Lee HO,
Zhang X, Jahnel M, Maharana S, Lemaitre R, Pozniakovsky A, Drechsel
D, et al: A molecular grammar governing the driving forces for
phase separation of Prion-like RNA binding proteins. Cell.
174:688–699.e16. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dominguez D, Freese P, Alexis MS, Su A,
Hochman M, Palden T, Bazile C, Lambert NJ, Van Nostrand EL, Pratt
GA, et al: Sequence, structure, and context preferences of human
RNA binding proteins. Mol Cell. 70:854–867.e9. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Holmqvist E and Vogel J: RNA-binding
proteins in bacteria. Nat Rev Microbiol. 16:601–615. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu Z, Xu L, Wan Y, Zhou J, Fu D, Chao H,
Bao K and Zeng T: Inhibition of E-cadherin expression by lnc-RNA
H19 to facilitate bladder cancer metastasis. Cancer Biomark.
22:275–281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Z, Wu J, Huang W, Peng J, Ye J, Yang
L, Yuan Y, Chen C, Zhang C, Cai S, et al: Long non-coding RNA
RP11-789C1.1 suppresses epithelial to mesenchymal transition in
gastric cancer through the RP11-789C1.1/miR-5003/E-cadherin axis.
Cell Physiol Biochem. 47:2432–2444. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He R, Zhang FH and Shen N: lncRNA
FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through
suppressing E-cadherin and regulating WNT pathway in non-small cell
lung cancer (NSCLC). Biomed Pharmacother. 95:331–338. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu L, Xu Z, Zhong L, Wang H, Jiang S,
Long Q, Xu J and Guo J: Enhancer of zeste homolog 2 (EZH2) promotes
tumour cell migration and invasion via epigenetic repression of
E-cadherin in renal cell carcinoma. BJU Int. 117:351–362. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ,
Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, et al: EZH2 supports
nasopharyngeal carcinoma cell aggressiveness by forming a
co-repressor complex with HDAC1/HDAC2 and Snail to inhibit
E-cadherin. Oncogene. 31:583–594. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Niu G, Zhuang H, Li B and Cao G: Long
noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by
regulating EZH2 and repressing E-cadherin in esophageal squamous
cell carcinoma. J BUON. 23:157–162. 2018.PubMed/NCBI
|
|
43
|
Petrova YI, Schecterson L and Gumbiner BM:
Roles for E-cadherin cell surface regulation in cancer. Mol Biol
Cell. 27:3233–3244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wong SHM, Fang CM, Chuah LH, Leong CO and
Ngai SC: E-cadherin: Its dysregulation in carcinogenesis and
clinical implications. Crit Rev Oncol Hematol. 121:11–22. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhai B, Yan HX, Liu SQ, Chen L, Wu MC and
Wang HY: Reduced expression of E-cadherin/catenin complex in
hepatocellular carcinomas. World J Gastroenterol. 14:5665–5673.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qiu Y, Liu Y, Li WH, Zhang HQ, Tian XX and
Fang WG: P2Y2 receptor promotes the migration and invasion of
breast cancer cells via EMT-related genes Snail and E-cadherin.
Oncol Rep. 39:138–150. 2018.PubMed/NCBI
|
|
48
|
Theys J, Jutten B, Habets R, Paesmans K,
Groot AJ, Lambin P, Wouters BG, Lammering G and Vooijs M:
E-Cadherin loss associated with EMT promotes radioresistance in
human tumor cells. Radiother Oncol. 99:392–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Menezes SV, Fouani L, Huang MLH, Geleta B,
Maleki S, Richardson A, Richardson DR and Kovacevic Z: The
metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB
signaling to enhance membrane E-cadherin expression in pancreatic
cancer cells. Carcinogenesis. 40:805–818. 2019. View Article : Google Scholar : PubMed/NCBI
|
